siRNA, Anti-MYO1D, 2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT11926WQ-2OMe)

The product SIRGT11926WQ-2OMe is a type of small interfering RNA (siRNA) that targets MYO1D gene and regulates the expression of gene. The siRNA interferes with the expression of MYO1D gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001303279.1; NM_001303280.1; NM_015194.2
Alternative Names PPP1R108; myr4
Related Diseases Canavan Disease, Refractive Error
Purification HPLC
Target Gene
Gene ID 4642
Uniprot ID O94832
Sub Cat Target Species Modification Scale  
SIRGT13926WQ-2MOE MYO1D Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT14926WQ-LNA MYO1D Human Locked Nucleic Acid (LNA) Inquiry
SIRGT11926WQ-RB MYO1D Human Ribo-modified Inquiry
SIRGT12926WQ-BB MYO1D Human Backbone-modified Inquiry

Related Products